FCG Investment Co has filed a Form 13F-HR disclosing its equity holdings as of the close of business on September 30, 2026. The filing lists 125 distinct securities held by the firm.
The portfolio is diversified across major technology, healthcare, and financial sectors. The largest position is in NVIDIA Corporation, with 23,414,888 shares. Other significant technology holdings include Microsoft Corporation (18,997,751 shares), Apple Inc (19,620,182 shares), Broadcom Inc (8,460,869 shares), and Taiwan Semiconductor Manufacturing Company (415,133 shares).
Healthcare and pharmaceutical companies represent a notable portion of the portfolio, with Eli Lilly & Co (3,406,444 shares), Merck & Co (2,071,539 shares), Pfizer Inc (621,622 shares), and Gilead Sciences Inc (1,008,919 shares) among the top holdings.
The filing also lists substantial positions in energy and industrial companies, including ExxonMobil Holdings Corp (437,960 shares), Chevron Corporation (2,045,776 shares), Caterpillar Inc (3,978,547 shares), and United Therapeutics Corp (1,680,943 shares). Additionally, the firm holds significant stakes in financial institutions such as JPMorgan Chase & Co (5,999,933 shares), Goldman Sachs Group Inc (3,599,639 shares), and Huntington Bancshares Inc (5,736,280 shares).
Exchange-traded funds comprise a large portion of the filing, with holdings in the SPDR S&P 500 ETF Trust (4,579,029 shares), the Invesco Exchange Traded Fund Trust II NASDAQ 100 ETF (11,372,394 shares), and the Vanguard Index Funds Morningstar Total Stock Market ETF (608,140 shares).
